Overview

Pharmacokinetic Properties of Sertraline Before and After Gastric Bypass Surgery

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate how the body absorbs and processes the medication sertraline (Zoloft®) before compared to how it is absorbed at two time points after gastric bypass surgery. Participants will be asked to take part in this study at three time points: 1) before their bariatric surgery, 2) at three months following the surgery, and 3) twelve months following surgery. This study will enroll approximately 30 participants.
Phase:
Phase 3
Details
Lead Sponsor:
North Dakota State University
Collaborator:
National Institutes of Health (NIH)
Treatments:
Sertraline